Reaching Out to Adolescents at High Risk of HIV Infection in Brazil: Demand Creation Strategies for PrEP and Other HIV Combination Prevention Methods

Imagem de Miniatura
Arquivos
art_MAGNO_Reaching_Out_to_Adolescents_at_High_Risk_of_2023.PDF (980.87 KB)
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER/PLENUM PUBLISHERS
Autores
MAGNO, Laio
SOARES, Fabiane
ZUCCHI, Eliana Miura
EUSTORGIO, Marcos
FERRAZ, Dulce
GRECO, Dirceu
ESCUDER, Maria Mercedes
DOURADO, Ines
Citação
ARCHIVES OF SEXUAL BEHAVIOR, v.52, n.2, p.703-719, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Using baseline data from the PrEP1519 cohort, in this article we aimed to analyze: (i) the effectiveness of demand creation strategies (DCS) to enroll adolescent men who have sex with men (AMSM) and adolescent transgender women (ATGW) into an HIV combination prevention study in Brazil; (ii) the predictors of DCS for adolescents' enrollment; and (iii) the factors associated with DCS by comparing online and face-to-face strategies for enrollment. The DCS included peer recruitment (i.e., online and face-to-face) and referrals from health services and non-governmental organizations (NGOs). AMSM and ATGW who agreed to participate in the study could opt to enroll in either PrEP (PrEP arm) or to use other prevention methods (non-PrEP arm). Bivariate and multivariate analyses were conducted and logistic regression odds ratios were estimated. The DCS reached 4529 AMSM and ATGW, the majority of which were derived online (73.8%). Of this total, 935 (20.6%) enrolled to participate (76.6% in PrEP arm and 23.4% in non-PrEP arm). The effectiveness of enrolling adolescents into both arms was greater via direct referrals (235/382 and 84/382, respectively) and face-to-face peer recruitment (139/670 and 35/670, respectively) than online (328/3342). We found that a combination under DCS was required for successful enrollment in PrEP, with online strategies majorly tending to enroll adolescents of a higher socioeconomic status. Our findings reinforce the need for DCS that actively reaches out to all adolescents at the greatest risk for HIV infection, irrespective of their socioeconomic status.
Palavras-chave
HIV pre-exposure prophylaxis, Adolescent, Demand creation, Men who have sex with men, Transgender women, Brazil
URI
https://observatorio.fm.usp.br/handle/OPI/53140
Referências
  1. Bastos FI, 2018, MEDICINE, V97, pS16, DOI [10.1097/MD.0000000000009447, 10.1097/md.0000000000009447]
  2. Bradley ELP, 2020, J RACIAL ETHN HEALTH, V7, P36, DOI 10.1007/s40615-019-00631-7
  3. Brandao ER, 2019, SEX REPROD HLTH MATT, V27, P76, DOI 10.1080/26410397.2019.1669338
  4. Brasil, 2020, B EPIDEMIOLOGICO HIV
  5. Brasil, 2020, PAINEL PREP
  6. Burki T, 2016, LANCET INFECT DIS, V16, P26, DOI 10.1016/S1473-3099(15)00494-6
  7. Celum CL, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25298
  8. Chan PA, 2018, SEX TRANSM DIS, V45, P462, DOI [10.1097/OLQ.0000000000000784, 10.1097/olq.0000000000000784]
  9. Chesser A, 2016, INFORM HEALTH SOC CA, V41, P1, DOI 10.3109/17538157.2014.948171
  10. Coelho LE, 2021, AIDS BEHAV, V25, P3223, DOI 10.1007/s10461-021-03180-5
  11. DeMaria LM, 2009, REV PANAM SALUD PUBL, V26, P485, DOI 10.1590/S1020-49892009001200003
  12. Dourado I, 2020, AIDS BEHAV, V24, P1994, DOI 10.1007/s10461-020-02927-w
  13. Du Bois SN, 2012, AIDS BEHAV, V16, P1430, DOI 10.1007/s10461-011-0058-0
  14. Dubov A, 2018, AM J MENS HEALTH, V12, P1843, DOI 10.1177/1557988318797437
  15. Felisbino-Mendes Mariana Santos, 2018, Rev. bras. epidemiol., V21, pe180013, DOI 10.1590/1980-549720180013.supl.1
  16. Grangeiro A., 2021, 11 IAS C HIV SCI
  17. Grinsztejn B, 2017, LANCET HIV, V4, pE169, DOI 10.1016/S2352-3018(17)30015-2
  18. Guimaraes AC., 2016, REV DIGITAL DIREITO, V3, P512, DOI [10.11606/issn.2319-0558.v3i3p512-524, DOI 10.11606/ISSN.2319-0558.V3I3P512-524]
  19. Hatzenbuehler ML, 2016, PEDIATR CLIN N AM, V63, P985, DOI 10.1016/j.pcl.2016.07.003
  20. Hosek SG, 2017, JAMA PEDIATR, V171, P1063, DOI 10.1001/jamapediatrics.2017.2007
  21. Hosek SG, 2017, JAIDS-J ACQ IMM DEF, V74, P21, DOI 10.1097/QAI.0000000000001179
  22. Ippoliti NB, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0276-z
  23. Jarrett SB, 2018, AIDS BEHAV, V22, pS57, DOI 10.1007/s10461-018-2058-9
  24. Jaspan HB, 2011, J ADOLESCENT HEALTH, V49, P42, DOI 10.1016/j.jadohealth.2010.10.009
  25. Kerr L, 2018, MEDICINE, V97, pS9, DOI [10.1097/MD.0000000000010573, 10.1097/md.0000000000010573]
  26. Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504
  27. Lightfoot MA, 2018, JAIDS-J ACQ IMM DEF, V79, P38, DOI [10.1097/qai.0000000000001726, 10.1097/QAI.0000000000001726]
  28. Magno L., 2021, ORAL ABSTRACTS 11 IA, DOI [10.1002/jia2.25755, DOI 10.1002/JIA2.25755]
  29. Magno L, 2022, SEX EDUC-SEX SOC LEA, DOI 10.1080/14681811.2022.2047017
  30. Magno L, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00135917, 10.1590/0102-311x00135917]
  31. Magno L, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00112718, 10.1590/0102-311x00112718]
  32. Magno L, 2019, GLOB PUBLIC HEALTH, V14, P1098, DOI 10.1080/17441692.2019.1571090
  33. Magno L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194306
  34. Maloney KM, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25439
  35. Mashora MC, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030814
  36. Melesse DY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002231
  37. Nishijima M, 2017, TELECOMMUN POLICY, V41, P12, DOI 10.1016/j.telpol.2016.10.004
  38. Ongwandee S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201171
  39. Paiva V, 2020, INTERFACE-BOTUCATU, V24, DOI [10.1590/interface.180625, 10.1590/Interface.180625]
  40. Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1
  41. Peng K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11058
  42. Rao A, 2021, JAIDS-J ACQ IMM DEF, V87, P644, DOI 10.1097/QAI.0000000000002620
  43. Rose-Clarke K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210468
  44. Saffier IP, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2795-9
  45. Sanchez TH, 2020, AIDS BEHAV, V24, P2024, DOI 10.1007/s10461-020-02894-2
  46. Soares F, 2019, AIDS BEHAV, V23, P2710, DOI 10.1007/s10461-019-02501-z
  47. Sperhacke RD, 2018, MEDICINE, V97, pS25, DOI [10.1097/MD.0000000000009014, 10.1097/md.0000000000009014]
  48. Sullivan PS, 2021, MHEALTH, V7, DOI 10.21037/mhealth-20-71
  49. Szwarcwald Célia Landmann, 2005, Clinics, V60, P367, DOI 10.1590/S1807-59322005000500004
  50. Szwarcwald CL, 2011, CAD SAUDE PUBLICA, V27, pS19, DOI 10.1590/S0102-311X2011001300003
  51. Tolley Elizabeth E, 2014, J Int AIDS Soc, V17, P19149, DOI 10.7448/IAS.17.3.19149
  52. UNAIDS, 2020, GLOB AIDS UPD 2020 S
  53. Whiteley LB, 2018, J PRIM PREV, V39, P361, DOI 10.1007/s10935-018-0514-y
  54. Zucchi EM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249293

Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros
Artigos e Materiais de Revistas Científicas - LIM/39
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/05